Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171733967> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2171733967 endingPage "e39" @default.
- W2171733967 startingPage "e39" @default.
- W2171733967 abstract "We thank Dr. Niciu and his colleagues for their interest and comments on our recent article ( 1 Kishimoto A. Kaneko M. Gotoh T. Hashimoto K. Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse. Biol Psychiatry. 2012; 71: e7-e8 Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar ). In this study, we reported that ifenprodil, an antagonist of the NR2B subunit of the N-methyl-D-aspartate (NMDA) receptor, was effective for treating flashbacks in female posttraumatic stress disorder (PTSD) patients with a history of childhood sexual abuse. Ketamine, another NMDA receptor antagonist, binds to the phencyclidine (PCP) site on the NMDA receptor and induces robust and rapid antidepressant effects in numerous open-label and randomized controlled trials in patients with major depression and bipolar depression ( 2 aan Het Rot M Zarate Jr, C.A. Charney D.S. Mathew S.J. Ketamine for depression: Where do we go from here?. Biol Psychiatry. 2012; 72: 537-547 Abstract Full Text Full Text PDF PubMed Scopus (289) Google Scholar ). In contrast, it is known that ketamine can also induce dissociative symptoms and perceptual alterations (i.e., depersonalization, derealization, and altered auditory and visual acuity), akin to those observed in PTSD ( 3 Krystal J.H. Karper L.P. Seibyl J.P. Freeman G.K. Delaney R. Bremner J.D. et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994; 51: 199-214 Crossref PubMed Scopus (2675) Google Scholar ). This led to a reanalysis of the completed clinical trials data to determine whether ketamine differentially worsened dissociation in subjects with a history of trauma with or without PTSD ( 4 Zeng M, Niciu M.J, Luckenbaugh DA, Ionescu DF, Mathews DC, Richards EM, et al. (in press): Acute stress symptoms do not worsen in PTSD and abuse with a single subanesthetic dose of ketamine. Biol Psychiatry Google Scholar ). In their three randomized, controlled, crossover studies (n = 55), 10 subjects with PTSD, 12 subjects with a history of sexual abuse, and 8 subjects with a history of physical abuse were examined. The latter two groups did not meet PTSD criteria. In this analysis, they failed to uncover a clinically significant increase in positive symptoms of psychosis, dissociative symptoms, or anxiety between the groups after observing patients for 1 week after a single subanesthetic dose of ketamine, although it is possible that repeated or larger doses of ketamine could exacerbate PTSD-like dissociation ( 4 Zeng M, Niciu M.J, Luckenbaugh DA, Ionescu DF, Mathews DC, Richards EM, et al. (in press): Acute stress symptoms do not worsen in PTSD and abuse with a single subanesthetic dose of ketamine. Biol Psychiatry Google Scholar ). It seems feasible that although both ifenprodil and ketamine are NMDA receptor antagonists, their modes of action differ. Acute Stress Symptoms Do Not Worsen in Posttraumatic Stress Disorder and Abuse with a Single Subanesthetic Dose of KetamineBiological PsychiatryVol. 73Issue 12PreviewIn the February 15, 2012 edition of Biological Psychiatry, Kishimoto and colleagues reported that ifenprodil(1), an N-methyl-D-aspartate (NMDA) receptor antagonist that selectively binds to the NR2B subunit, markedly reduced flashbacks in three Japanese women with posttraumatic stress disorder (PTSD) due to sexual abuse. The authors noted that ifenprodil has a mechanism of action similar to ketamine, a noncompetitive NMDA receptor antagonist. Ketamine has been shown to have robust and rapid antidepressant effects in numerous open-label and randomized controlled trials, including three placebo-controlled studies from our group (2–4). Full-Text PDF" @default.
- W2171733967 created "2016-06-24" @default.
- W2171733967 creator A5004455538 @default.
- W2171733967 creator A5032453300 @default.
- W2171733967 date "2013-06-01" @default.
- W2171733967 modified "2023-09-23" @default.
- W2171733967 title "Reply to: Acute Stress Symptoms Do Not Worsen in Posttraumatic Stress Disorder and Abuse with a Single Subanesthetic Dose of Ketamine" @default.
- W2171733967 cites W1997566439 @default.
- W2171733967 cites W2002206629 @default.
- W2171733967 cites W2024071094 @default.
- W2171733967 cites W2028884770 @default.
- W2171733967 cites W2044325416 @default.
- W2171733967 cites W2092572691 @default.
- W2171733967 cites W2194134614 @default.
- W2171733967 doi "https://doi.org/10.1016/j.biopsych.2012.10.018" @default.
- W2171733967 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23245748" @default.
- W2171733967 hasPublicationYear "2013" @default.
- W2171733967 type Work @default.
- W2171733967 sameAs 2171733967 @default.
- W2171733967 citedByCount "2" @default.
- W2171733967 countsByYear W21717339672019 @default.
- W2171733967 countsByYear W21717339672021 @default.
- W2171733967 crossrefType "journal-article" @default.
- W2171733967 hasAuthorship W2171733967A5004455538 @default.
- W2171733967 hasAuthorship W2171733967A5032453300 @default.
- W2171733967 hasConcept C118552586 @default.
- W2171733967 hasConcept C124315065 @default.
- W2171733967 hasConcept C126322002 @default.
- W2171733967 hasConcept C15744967 @default.
- W2171733967 hasConcept C170493617 @default.
- W2171733967 hasConcept C2776502132 @default.
- W2171733967 hasConcept C2778807096 @default.
- W2171733967 hasConcept C2780376555 @default.
- W2171733967 hasConcept C2780795376 @default.
- W2171733967 hasConcept C67018056 @default.
- W2171733967 hasConcept C71924100 @default.
- W2171733967 hasConceptScore W2171733967C118552586 @default.
- W2171733967 hasConceptScore W2171733967C124315065 @default.
- W2171733967 hasConceptScore W2171733967C126322002 @default.
- W2171733967 hasConceptScore W2171733967C15744967 @default.
- W2171733967 hasConceptScore W2171733967C170493617 @default.
- W2171733967 hasConceptScore W2171733967C2776502132 @default.
- W2171733967 hasConceptScore W2171733967C2778807096 @default.
- W2171733967 hasConceptScore W2171733967C2780376555 @default.
- W2171733967 hasConceptScore W2171733967C2780795376 @default.
- W2171733967 hasConceptScore W2171733967C67018056 @default.
- W2171733967 hasConceptScore W2171733967C71924100 @default.
- W2171733967 hasFunder F4320320912 @default.
- W2171733967 hasIssue "12" @default.
- W2171733967 hasLocation W21717339671 @default.
- W2171733967 hasLocation W21717339672 @default.
- W2171733967 hasOpenAccess W2171733967 @default.
- W2171733967 hasPrimaryLocation W21717339671 @default.
- W2171733967 hasRelatedWork W2024002085 @default.
- W2171733967 hasRelatedWork W2026776441 @default.
- W2171733967 hasRelatedWork W2033257871 @default.
- W2171733967 hasRelatedWork W2415098049 @default.
- W2171733967 hasRelatedWork W3031943403 @default.
- W2171733967 hasRelatedWork W3211580965 @default.
- W2171733967 hasRelatedWork W4220721136 @default.
- W2171733967 hasRelatedWork W4229020297 @default.
- W2171733967 hasRelatedWork W4295605197 @default.
- W2171733967 hasRelatedWork W4386529446 @default.
- W2171733967 hasVolume "73" @default.
- W2171733967 isParatext "false" @default.
- W2171733967 isRetracted "false" @default.
- W2171733967 magId "2171733967" @default.
- W2171733967 workType "article" @default.